TheProfitWatch

CDTX - Cidara Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
109.96 -4.48 (-4.07%) --- --- --- --- -4.38 (-3.98%) -0.14 (-0.13%) -0.14 (-0.13%)

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.65
Diluted EPS:
-1.65
Basic P/E:
-63.9273
Diluted P/E:
-63.9273
RSI(14) 1m:
0.0
VWAP:
105.57
RVol:
0.6855

Events

Period Kind Movement Occurred At
1m Price increase 1m 110.54 +1.32 (+1.21%) Oct 15 09:31

Related News